Puja R. Mehta

Queen Mary University of London — United Kingdom

Medicine · Health Sciences

23h-index3.2kcitations60works16.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyotrophic Lateral Sclerosis Research(16), Neurogenetic and Muscular Disorders Research(11), RNA Research and Splicing(7), Long-Term Effects of COVID-19(6), Venous Thromboembolism Diagnosis and Management(4)

Publications60 total

U7 small nuclear RNA splice-switching therapeutics for STMN2 and UNC13A in Amyotrophic Lateral Sclerosis
2025Open Access
Sensitivity to TDP-43 loss and degradation resistance determine cryptic exon biomarker potential
2025Open Access
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD
Nature Neuroscience·2025· 5 citedOpen Access
TDP-43 loss induces cryptic polyadenylation in ALS/FTD
Nature Neuroscience·2025· 10 citedOpen Access
Prospective study to analyze the yield and clinical impact of trio exome sequencing in 137 Indian children with autism spectrum disorder
Journal of Human Genetics·2025
Standardization Of Aaturahasta Prasrita Pramana Of Vasti- An Observational Study
International Journal of Environmental Sciences·2025Open Access
Altered mRNA transport and local translation in i3Neurons with RNA-binding protein knockdown
Nucleic Acids Research·2025· 3 citedOpen Access
STUDY OF DEPENDENCE OF BURN RATE PARAMETERS OF GUN PROPELLANT ON PRESSURE AND ITS EFFECT ON PERFORMANCE PREDICTION
2025
Creation of de novo cryptic splicing for ALS and FTD precision medicine
Science·2024· 27 citedOpen Access
Altered mRNA transport and local translation in iNeurons with RNA binding protein knockdown
2024· 3 citedOpen Access
Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
Nature Communications·2024Open Access
Loss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOs
2024· 25 citedOpen Access
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Science Translational Medicine·2024· 134 citedOpen Access
TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTD
2024· 23 citedOpen Access
Creation of de novo cryptic splicing for ALS/FTD precision medicine
2023· 5 citedOpen Access
Olanzapine, Risperidone and Clozapine prescribing is associated with increased risk for Alzheimer’s Disease reflecting antipsychotic-specific effects on microglial phagocytosis
2023· 3 citedOpen Access
Guillain-Barre Syndrome Presenting Alongside Lupus Nephritis: Case and Management
Journal of the American Society of Nephrology·2023· 1 cited
The era of cryptic exons: implications for ALS-FTD
Molecular Neurodegeneration·2023· 130 citedOpen Access
The role of the electroencephalogram (EEG) in determining the aetiology of catatonia: a systematic review and meta-analysis of diagnostic test accuracy
EClinicalMedicine·2023· 19 citedOpen Access
Molecular dynamics analysis of Superoxide Dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression
2022· 7 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Matthew J. Keuss(8), Ammar Al‐Chalabi(8), Arpan R. Mehta(7), Matteo Zanovello(7), Pietro Fratta(6), Yue Qi(5), Oscar G. Wilkins(5), Andrea Malaspina(5), Sarah Opie-Martin(5), Christopher E. Shaw(5), Simone Barattucci(5), Ross W. Paterson(4), Rachel Brown(4), Laura Benjamin(4), Stephen Keddie(4), Arvind Chandratheva(4), Anna M. Checkley(4), Catherine Houlihan(4), Michael P. Lunn(4), David J. Werring(4)